Neuronal damage after moderate hypoxia and erythropoietin

被引:40
作者
Weber, A
Dzietko, M
Berns, M
Felderhoff-Mueser, U
Heinemann, U
Maier, RF
Obladen, M
Ikonomidou, C
Bührer, C
机构
[1] Dept Neonatol, Berlin, Germany
[2] Charite Univ, Med Ctr, Dept Neurophysiol, Berlin, Germany
[3] Univ Marburg, Dept Neonatol & Neuropediat, Marburg, Germany
[4] Carl Gustav Carus Univ, Med Ctr, Dept Neuropediat, Dresden, Germany
[5] Univ Basel, Childrens Hosp, Basel, Switzerland
关键词
erythropoietin; brain; hypoxia; preconditioning; neuroprotection;
D O I
10.1016/j.nbd.2005.04.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Both mild hypoxia and exogenous erythropoietin may protect the brain against subsequent severe hypoxia, and the conditioning effect of transient hypoxia is partly mediated by hypoxia-induced endogenous erythropoietin. We now observed in several experimental models that combining transient hypoxia and exogenous erythropoietin may cause neuronal damage. High-dose erythropoietin (40 IU/ml) profoundly impeded synaptic transmission of rat hippocampal slice cultures when used in conjunction with moderate hypoxia (10% O-2 for two 8-h periods). Addition of erythropoietin increased viability of cultured rat embryonic cortical neurons at 21% O-2 but decreased viability under hypoxic conditions (2% O-2) in a dose-dependent fashion. Death of human neuronal precursor cells challenged by oxygen and glucose deprivation was increased by erythropoietin when cells were cultured under hypoxic but not under normoxic conditions. In neonatal rats exposed to moderate hypoxia plus erythropoietin, numbers of degenerating cerebral neurons were increased, as compared to controls or rats subjected to either hypoxia or erythropoietin alone. Thus, erythropoietin may aggravate rather than ameliorate neuronal damage when administered during transient hypoxia. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:594 / 600
页数:7
相关论文
共 39 条
[1]   Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain [J].
Bernaudin, M ;
Nedelec, AS ;
Divoux, D ;
MacKenzie, ET ;
Petit, E ;
Schumann-Bard, P .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (04) :393-403
[2]   A potential role for erythropoietin in focal permanent cerebral ischemia in mice [J].
Bernaudin, M ;
Marti, HH ;
Roussel, S ;
Divoux, D ;
Nouvelot, A ;
MacKenzie, E ;
Petit, E .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (06) :643-651
[3]   Antiepileptic drugs and apoptotic neurodegeneration in the developing brain [J].
Bittigau, P ;
Sifringer, M ;
Genz, K ;
Reith, E ;
Pospischil, D ;
Govindarajalu, S ;
Dzietko, M ;
Pesditschek, S ;
Mai, I ;
Dikranian, K ;
Olney, JW ;
Ikonomidou, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :15089-15094
[4]   SERUM-FREE B27/NEUROBASAL MEDIUM SUPPORTS DIFFERENTIATED GROWTH OF NEURONS FROM THE STRIATUM, SUBSTANTIA-NIGRA, SEPTUM, CEREBRAL-CORTEX, CEREBELLUM, AND DENTATE GYRUS [J].
BREWER, GJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (05) :674-683
[5]   Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor [J].
Brines, M ;
Grasso, G ;
Fiordaliso, F ;
Sfacteria, A ;
Ghezzi, P ;
Fratelli, M ;
Latini, R ;
Xie, QW ;
Smart, J ;
Su-Rick, CJ ;
Pobre, E ;
Diaz, D ;
Gomez, D ;
Hand, C ;
Coleman, T ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14907-14912
[6]   Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].
Brines, ML ;
Ghezzi, P ;
Keenan, S ;
Agnello, D ;
de Lanerolle, NC ;
Cerami, C ;
Itri, LM ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531
[7]   FOSFOMYCIN DOES NOT REDUCE CYTOSTATIC ACTIVITY OF CISPLATINUM AGAINST HUMAN OSTEOSARCOMA CELL-LINES INVITRO [J].
BUHRER, C ;
ATZPODIEN, J ;
OZ, S ;
HENZE, G .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1991, 8 (03) :243-249
[8]   Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling [J].
Cohen, J ;
Oren-Young, L ;
Klingmuller, U ;
Neumann, D .
BIOCHEMICAL JOURNAL, 2004, 377 :517-524
[9]   IMPROVED CUPRIC-SILVER METHOD FOR IMPREGNATION OF AXONAL AND TERMINAL DEGENERATION [J].
DEOLMOS, JS ;
INGRAM, WR .
BRAIN RESEARCH, 1971, 33 (02) :523-&
[10]   Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades [J].
Digicaylioglu, M ;
Lipton, SA .
NATURE, 2001, 412 (6847) :641-647